AI assistant
Sending…
NeuroPace Inc — Director's Dealing 2021
Apr 26, 2021
33194_dirs_2021-04-26_8502ef85-faa6-470c-b694-b1ee5e373b60.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-04-26
Reporting Person: LACOB JOSEPH (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-26 | Common Stock | A | 334027 | $0.00 | Acquired | 351920 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-26 | Series A' Preferred Stock | $0.00 | C | 8594 | Disposed | Common Stock (8594) | Indirect | |
| 2021-04-26 | Series A' Preferred Stock | $0.00 | C | 17189 | Disposed | Common Stock (17189) | Indirect | |
| 2021-04-26 | Series B; Preferred Stock | $0.00 | C | 102747 | Disposed | Common Stock (102747) | Indirect | |
| 2021-04-26 | Series B' Preferred Stock | $0.00 | C | 205497 | Disposed | Common Stock (20549) | Indirect |
Footnotes
F1: Includes 111,341 shares held by Lacob Ventures LLC and 222,686 shares held by LCT18 Investments, LLC.
F2: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.
F3: Shares are held by Lacob Ventures LLC.
F4: Shares are held by LCT18 Investments.
More from NeuroPace Inc
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 21
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 4
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 23